QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 37m ago

105last 24h

3127last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: BMYsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

The Wall Street Journal94d agoneutral

Deal or No Deal, AstraZeneca Stock Is a Bargain

Pharma Voice94d agoneutral

What the AstraZeneca-BMS rumors reveal about pharma megamergers

MarketBeat94d agoneutral

Schrodinger Q2 Earnings Call Highlights

BioPharma Dive95d agoneutral

Cardiac drug developer Braveheart banks more than $382M in IPO

The Wall Street Journal95d agoneutral

💬 Money Quote: Novo Nordisk CEO

Stocktwits95d agoneutral

AstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks - ‘There Never Was A Deal To Be Done’

Reuters95d agoneutral

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Quartz95d agoneutral

AstraZeneca and Bristol Myers Squibb merger talks denied

The Wall Street Journal95d agoneutral

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

TheStreet96d agoneutral

AstraZeneca-BMY megadeal talk sparks huge market rift

Proactive96d agoneutral

Brokers split on AstraZeneca merger talk as shares recover some ground

MarketBeat96d agoneutral

BioNTech Q2 Earnings Call Highlights

Barrons.com96d agoneutral

AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open

ABBV BMY LLY PFE

Axios96d agoneutral

How a pharma megamerger could squelch R&D

Motley Fool97d agoneutral

Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript

Moby97d agoneutral

AstraZeneca Eyes a Pharma Megamerger Nobody Asked For

Bloomberg97d agoneutralVIDEO

AstraZeneca Investors See Little Logic in Bristol Tie-Up

PA Media: Money97d agoneutral

Stocks mixed as AstraZeneca merger talk dents FTSE 100

ABBV BMY JNJ LLY

Investing.com97d agoneutral

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?

MT Newswires97d agoneutral

European Stocks Close Mostly Higher in Monday Trading; AstraZeneca Reportedly in Merger Talks With Bristol Myers

Zacks97d agoneutral

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Investor's Business Daily97d agoneutral

AstraZeneca Stock Nosedives On Mega-Merger Rumor

Quartz97d agoneutral

AstraZeneca, Bristol Myers Squibb exploring merger talks

MT Newswires97d agoneutral

Stocks Rise Pre-Bell as Trump Calls Off Planned Iran Strikes; Labor Market Data, Corporate Earnings on Deck

AMD BMY CAT DIS LLY MCD MRK PLTR+6

TheStreet97d agoneutral

Morgan Stanley uncovers major Bristol Myers stock signals

The Wall Street Journal97d agoneutral

Health Care Roundup: Market Talk

Reuters97d agoneutral

Wall St futures edge up on Mideast deal hopes; healthcare in focus

Simply Wall St.97d agoneutral

Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca

PA Media: Money97d agoneutral

AstraZeneca in talks over £300bn mega-merger with US rival - reports

Reuters98d agoneutral

AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says